Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Model of cetuximab resistance in CRC allows testing of other treatments

June 30, 2015

SB-204 8% is well-tolerated in subjects with acne vulgaris

June 30, 2015

Immunomodulatory progenitor cells show promise to mitigate ICR in heart failure

June 29, 2015

Phase I data influence future development of LY-3022856

June 29, 2015

RepliCel describes the potential of cell therapies to treat tendinosis and aging skin

June 29, 2015

Trial finds RVX-208 may benefit individuals with prediabetes

June 29, 2015

ESHG highlights: characterization of disease-associated gene mutations

June 29, 2015

Single dose of AAVrh.10anti-IgE blocks peanut-induced anaphylaxis

June 26, 2015

First-in-human study shows promising results for a novel EGFR TKI

June 26, 2015

MicroBiome Therapeutics discloses clinical data on the antidiabetic drug NM-505

June 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...